- Douglas Pharmaceuticals has appointed Sean Westbrook as Chief Executive Officer.
- Westbrook brings pharmaceutical leadership experience across commercial operations and manufacturing in international markets, most recently serving as Managing Director of AROTEC Diagnostics in New Zealand.
Douglas Pharmaceuticals has appointed Sean Westbrook as Chief Executive Officer. The company announced the leadership change as it prepares for its next phase of development.
Westbrook brings experience across the pharmaceutical sector, with leadership roles spanning commercial operations and manufacturing in international markets. His previous positions include roles at Aspen Holdings, Sun Pharma and Tiger Brands. Most recently, he served as Managing Director of AROTEC Diagnostics in New Zealand.
According to the company, Westbrook’s experience and leadership approach align with the values that have guided Douglas for nearly 60 years, including a long-term view, a focus on quality and capability, and a commitment to people.
Douglas Pharmaceuticals stated it looks forward to the next chapter under Westbrook’s leadership.
